Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC): Stock That Needs Special Handling
Currently, there are 12.96M common shares owned by the public and among those 10.41M shares have been available to trade. The company’s stock has a 5-day price change of -78.98% and -92.99% over the past three months. CYCC shares are trading -94.27% year to date (YTD), with the 12-month market performance down to -98.98% lower. […]
Some Investing Thoughts On Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC)
Cyclacel Pharmaceuticals Inc (CYCC) concluded trading on Thursday at a closing price of $0.61, with 5.48 million shares of worth about $3.34 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -90.78% during that period and on Thursday the price saw a loss of […]
Now Is A Suitable Moment For A Long-Term Purchase Of Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC)
Currently, there are 207.34M common shares owned by the public and among those 12.71M shares have been available to trade. The company’s stock has a 5-day price change of 35.15% and -24.92% over the past three months. CYCC shares are trading -24.12% year to date (YTD), with the 12-month market performance down to -87.60% lower. […]